Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: DUSA Pharmaceuticals, Inc.
Current Parent CompanySun Pharmaceuticals
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $20,750,000
Year: 2020
Date: August 24, 2020
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Violation Description: Massachusetts-based DUSA Pharmaceuticals, Inc., a subsidiary of Sun Pharmaceutical Industries, Inc., agreed to pay the United States $20.75 million to resolve allegations that it caused physicians to submit false claims to Medicare and the Federal Employee Health Benefit Program by knowingly promoting an administration process for the drug Levulan Kerastick that contradicted the product instructions approved by the U.S. Food and Drug Administration and was unsupported by sufficient clinical evidence.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
Facility State: Massachusetts
HQ Country of Current Parent: India
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.